Manipulating DNA repair enzymes to examine the interactions between aging and Alzheimers disease with iPSC-derived microglia
操纵 DNA 修复酶以检查衰老和阿尔茨海默病与 iPSC 衍生的小胶质细胞之间的相互作用
基本信息
- 批准号:10153612
- 负责人:
- 金额:$ 38.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-07-15 至 2022-04-30
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalAddressAgeAgingAlzheimer&aposs DiseaseAlzheimer&aposs disease modelAlzheimer&aposs disease riskApoptosisAstrocytesAutopsyBioinformaticsBlood VesselsBrainCell Differentiation processCellsChronologyClustered Regularly Interspaced Short Palindromic RepeatsCockayne SyndromeDNADNA RepairDNA Repair EnzymesDataDefectDeletion MutationDevelopmentDiseaseERCC1 geneExhibitsFibroblastsGene DeletionGene ExpressionGenerationsGenesGenetic TranscriptionGenetic studyGoalsHumanImpaired cognitionImpairmentIndividualInflammatoryInflammatory ResponseKnock-outKnockout MiceMediatingMethodsMicrogliaModelingMusMutateMutationNeurogliaNeurologicNeurologic SignsNeurologic SymptomsNeuronsOligodendrogliaOrganoidsPathogenesisPathologyPathway AnalysisPatientsPhagocytosisPhenotypePremature aging syndromeProductionProgeriaProteinsProtocols documentationReactive Oxygen SpeciesResearch PersonnelResourcesRisk FactorsRoleSignal TransductionSourceStimulusStrokeSuperoxidesSyndromeSystemTestingTissuesTranscriptTransgenic Organismsage effectagedaging brainbasecytokinedopaminergic neurongene functiongenetic manipulationinduced pluripotent stem cellinnovationmigrationmultidisciplinarymutantnerve stem cellneuropathologyneuroregulationnoveloverexpressionrelating to nervous systemresponsestem cell modeltranscriptometranscriptome sequencingyoung adult
项目摘要
Project Summary/Abstract
Microglia are strongly implicated in the pathogenesis of Alzheimer's disease (AD) and recent genetic studies
have identified several microglial-enriched genes that influence AD risk. To study the role of these genes in AD
our lab recently developed a fully-defined approach to differentiate induced pluripotent stem cells (iPSCs) into
microglia. However, reprogramming erases many of the key signatures of aging, making it difficult to study the
interactions between AD genes, pathology, and aging with iPSC-derived cells. One recent study developed an
innovative approach to address this challenge by using Progerin, a protein associated with a premature aging
disorder. However, the Progerin gene, LMNA, is not normally expressed in human neurons or glia. In
contrast, another form of Progeria, Cockayne Syndrome (CS), which is caused by mutations that impair DNA
repair, leads to significant neurological defects. Furthermore, two of the genes that are mutated in CS, ERCC1
and ERCC5, are highly expressed in human microglia and their deletion in mice mimics key aspects of
microglial aging. Given these findings, we propose to test the hypothesis that deletion or mutations of ERCC1
and ERCC5 will produce changes in iPSC-derived microglia that mimic the effects of chronological aging and
impair the response of microglia to AD-associated insults. To achieve these goals, we have assembled a
multidisciplinary team who bring expertise in AD iPSC modeling, CRISPR-mediated gene deletion, and
microglial differentiation and analysis, RNA-sequencing and bioinformatics, and brain organoid culture systems
to test following three specific aims and hypotheses: Aim 1: Examine the impact of ERCC1/5 deletions and
mutations on iPSC-derived microglial function. We hypothesize that ERCC knockout and mutant microglia will
exhibit an age-associated `primed' activation state with impaired homestatic activity but exacerbated
inflammatory responses. Aim 2: Do ERCC1/5 deletions and mutations model the transcriptional effects of
aging observed in human brain-derived microglia? We hypothesize that deletion of these genes will produce
microglia that exhibit many of the transcriptional changes associated with natural brain aging. Aim 3: Defining
the intrinsic versus extrinsic effects of ERCC deletion on microglial aging with brain organoid cultures. We
hypothesis that both intrinsic and extrinsic signals influence microglial aging.
项目摘要/摘要
小胶质细胞与阿尔茨海默病(AD)的发病机制和最近的遗传学研究密切相关
已经确定了几个影响阿尔茨海默病风险的小胶质细胞丰富的基因。研究这些基因在阿尔茨海默病中的作用
我们的实验室最近开发了一种完全定义的方法来将诱导多能干细胞(IPSCs)分化为
小胶质细胞。然而,重新编程抹去了许多衰老的关键特征,使得研究
AD基因、病理和衰老与IPSC来源的细胞之间的相互作用。最近的一项研究开发了一种
通过使用Progerin来应对这一挑战的创新方法,Progerin是一种与过早衰老有关的蛋白质
无序。然而,Progerin基因LMNA通常不在人类神经元或神经胶质细胞中表达。在……里面
相比之下,另一种形式的早衰症,Cockayne综合征(CS),是由破坏DNA的突变引起的
修复,会导致严重的神经缺陷。此外,在CS中突变的两个基因ERCC1
和ERCC5在人小胶质细胞中高表达,它们在小鼠中的缺失模拟了
小胶质细胞老化。鉴于这些发现,我们建议检验ERCC1缺失或突变的假设
ERCC5将产生IPSC来源的小胶质细胞的变化,模拟时序老化和
损害小胶质细胞对AD相关侮辱的反应。为了实现这些目标,我们组建了一个
多学科团队,提供AD IPSC建模、CRISPR介导的基因删除和
小胶质细胞分化和分析、RNA测序和生物信息学以及脑器官培养系统
检验以下三个具体目标和假设:目标1:检查ERCC1/5缺失和
IPSC来源的小胶质细胞功能突变。我们假设ERCC基因敲除和突变的小胶质细胞
表现出与年龄相关的“启动”激活状态,家庭活动受损但加重
炎症反应。目的2:ERCC1/5缺失和突变是否模拟了ERCC1/5的转录效应
在人脑来源的小胶质细胞中观察到的衰老?我们假设这些基因的缺失会产生
小胶质细胞表现出许多与自然脑老化有关的转录变化。目标3:定义
用脑器官培养法研究ERCC缺失对小胶质细胞老化的内在和外在影响。我们
假设内在和外在信号都会影响小胶质细胞的衰老。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The P522R protective variant of PLCG2 promotes the expression of antigen presentation genes by human microglia in an Alzheimer's disease mouse model.
- DOI:10.1002/alz.12577
- 发表时间:2022-10
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
TREM2 regulates purinergic receptor-mediated calcium signaling and motility in human iPSC-derived microglia.
- DOI:10.7554/elife.73021
- 发表时间:2022-02-22
- 期刊:
- 影响因子:7.7
- 作者:Jairaman A;McQuade A;Granzotto A;Kang YJ;Chadarevian JP;Gandhi S;Parker I;Smith I;Cho H;Sensi SL;Othy S;Blurton-Jones M;Cahalan MD
- 通讯作者:Cahalan MD
A Bump-Hole Strategy for Increased Stringency of Cell-Specific Metabolic Labeling of RNA.
- DOI:10.1021/acschembio.0c00755
- 发表时间:2020-12-18
- 期刊:
- 影响因子:4
- 作者:Nguyen K;Kubota M;Arco JD;Feng C;Singha M;Beasley S;Sakr J;Gandhi SP;Blurton-Jones M;Fernández Lucas J;Spitale RC
- 通讯作者:Spitale RC
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mathew Mark Blurton-Jones其他文献
Mathew Mark Blurton-Jones的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mathew Mark Blurton-Jones', 18)}}的其他基金
A novel platform for the investigation of human microglia
研究人类小胶质细胞的新平台
- 批准号:
10337872 - 财政年份:2021
- 资助金额:
$ 38.63万 - 项目类别:
ENGINEERED HUMAN MICROGLIA AS A CELL-BASED THERAPY FOR A-BETA PLAQUE REMOVAL
工程化人类小胶质细胞作为 A-β 斑块去除的细胞疗法
- 批准号:
10475191 - 财政年份:2021
- 资助金额:
$ 38.63万 - 项目类别:
Manipulating DNA repair enzymes to examine the interactions between aging and Alzheimers disease with iPSC-derived microglia
操纵 DNA 修复酶以检查衰老和阿尔茨海默病与 iPSC 衍生的小胶质细胞之间的相互作用
- 批准号:
9924476 - 财政年份:2017
- 资助金额:
$ 38.63万 - 项目类别:
Manipulating DNA repair enzymes to examine the interactions between aging and Alzheimers disease with iPSC-derived microglia
操纵 DNA 修复酶以检查衰老和阿尔茨海默病与 iPSC 衍生的小胶质细胞之间的相互作用
- 批准号:
9360955 - 财政年份:2017
- 资助金额:
$ 38.63万 - 项目类别:
The role of TREM2 in human microglial function and Alzheimer disease pathogenesis
TREM2在人类小胶质细胞功能和阿尔茨海默病发病机制中的作用
- 批准号:
8758611 - 财政年份:2014
- 资助金额:
$ 38.63万 - 项目类别:
The Role of Beta-Amyloid Assembly States in Tau Pathology and Cognitive Decline
β-淀粉样蛋白组装状态在 Tau 病理学和认知衰退中的作用
- 批准号:
8054246 - 财政年份:2008
- 资助金额:
$ 38.63万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 38.63万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 38.63万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 38.63万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 38.63万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 38.63万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 38.63万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 38.63万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 38.63万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 38.63万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 38.63万 - 项目类别:
Research Grant